# WhiteHorse Finance, Inc.: financial statements, quarterly

WHF · Nasdaq · CIK 1552198 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/whf.md) · [Financials](/companies/whf/financials.md) · [Filings](/companies/whf/filings.md) · [Insiders](/companies/whf/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/whf/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [7.6](/filings/0001558370-24-014753.md) | [7.5 d](/filings/0001104659-26-024735.md) | [7.3](/filings/0001558370-25-007430.md) | [7.1](/filings/0001558370-25-010646.md) | [6.9](/filings/0001104659-25-108820.md) | [6.5 d](/filings/0001104659-26-024735.md) | [6.2](/filings/0001104659-26-056683.md) | [6.1](/filings/0001104659-26-093465.md) | [5.8](/filings/0001104659-25-108820.md) | [5.0 d](/filings/0001104659-26-024735.md) | [5.0](/filings/0001104659-26-056683.md) | [4.8](/filings/0001104659-26-093465.md) |
| Net income | $m | [5.6](/filings/0001558370-24-014753.md) | [3.4 d](/filings/0001104659-26-024735.md) | [6.0](/filings/0001558370-25-007430.md) | [7.8](/filings/0001558370-25-010646.md) | [(6.9)](/filings/0001104659-25-108820.md) | [3.9 d](/filings/0001104659-26-024735.md) | [4.3](/filings/0001104659-26-056683.md) | [2.3](/filings/0001104659-26-093465.md) | [(0.6)](/filings/0001104659-25-108820.md) | [8.4 d](/filings/0001104659-26-024735.md) | [(0.7)](/filings/0001104659-26-056683.md) | [10.4](/filings/0001104659-26-093465.md) |
| Diluted EPS | $ per share | [0.24](/filings/0001558370-24-014753.md) | not reported | [0.26](/filings/0001558370-25-007430.md) | [0.34](/filings/0001558370-25-010646.md) | [(0.30)](/filings/0001104659-25-108820.md) | not reported | [0.18](/filings/0001104659-26-056683.md) | [0.10](/filings/0001104659-26-093465.md) | [(0.02)](/filings/0001104659-25-108820.md) | not reported | [(0.03)](/filings/0001104659-26-056683.md) | [0.48](/filings/0001104659-26-093465.md) |
| Basic EPS | $ per share | [0.24](/filings/0001558370-24-014753.md) | not reported | [0.26](/filings/0001558370-25-007430.md) | [0.34](/filings/0001558370-25-010646.md) | [(0.30)](/filings/0001104659-25-108820.md) | not reported | [0.18](/filings/0001104659-26-056683.md) | [0.10](/filings/0001104659-26-093465.md) | [(0.02)](/filings/0001104659-25-108820.md) | not reported | [(0.03)](/filings/0001104659-26-056683.md) | [0.48](/filings/0001104659-26-093465.md) |

- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [10.6](/filings/0001558370-24-014753.md) | [10.7](/filings/0001104659-26-024735.md) | [12.9](/filings/0001558370-25-010646.md) | [12.9](/filings/0001558370-24-011468.md) | [11.2](/filings/0001104659-25-108820.md) | [12.4](/filings/0001104659-26-024735.md) | [11.4](/filings/0001104659-26-056683.md) | [10.5](/filings/0001104659-26-093465.md) | [9.5](/filings/0001104659-25-108820.md) | [7.0](/filings/0001104659-26-093465.md) | [11.8](/filings/0001104659-26-056683.md) | [8.5](/filings/0001104659-26-093465.md) |
| Total assets | $m | [747](/filings/0001558370-23-018420.md) | [731](/filings/0001410578-25-001398.md) | [735](/filings/0001558370-24-007193.md) | [703](/filings/0001558370-24-011468.md) | [684](/filings/0001558370-24-014753.md) | [677](/filings/0001104659-26-024735.md) | [679](/filings/0001558370-25-007430.md) | [671](/filings/0001558370-25-010646.md) | [626](/filings/0001104659-25-108820.md) | [615](/filings/0001104659-26-093465.md) | [606](/filings/0001104659-26-056683.md) | [604](/filings/0001104659-26-093465.md) |
| Total liabilities | $m | [424](/filings/0001558370-23-018420.md) | [414](/filings/0001410578-25-001398.md) | [421](/filings/0001558370-24-007193.md) | [391](/filings/0001558370-24-011468.md) | [387](/filings/0001558370-24-014753.md) | [391](/filings/0001104659-26-024735.md) | [397](/filings/0001558370-25-007430.md) | [396](/filings/0001558370-25-010646.md) | [361](/filings/0001104659-25-108820.md) | [355](/filings/0001104659-26-093465.md) | [356](/filings/0001104659-26-056683.md) | [351](/filings/0001104659-26-093465.md) |
| Long-term debt | $m | [398](/filings/0001558370-23-018420.md) | [386](/filings/0001410578-25-001398.md) | [390](/filings/0001558370-24-007193.md) | [359](/filings/0001558370-24-011468.md) | [353](/filings/0001558370-24-014753.md) | [353](/filings/0001104659-26-024735.md) | [361](/filings/0001558370-25-007430.md) | [363](/filings/0001558370-25-010646.md) | [324](/filings/0001104659-25-108820.md) | [324](/filings/0001104659-26-093465.md) | [324](/filings/0001104659-26-056683.md) | [324](/filings/0001104659-26-093465.md) |
| Shareholders' equity | $m | [322](/filings/0001558370-23-018420.md) | [317](/filings/0001410578-25-001398.md) | [314](/filings/0001558370-24-007193.md) | [313](/filings/0001558370-24-011468.md) | [297](/filings/0001558370-24-014753.md) | [286](/filings/0001104659-26-024735.md) | [281](/filings/0001558370-25-007430.md) | [275](/filings/0001558370-25-010646.md) | [265](/filings/0001104659-25-108820.md) | [260](/filings/0001104659-26-093465.md) | [250](/filings/0001104659-26-056683.md) | [253](/filings/0001104659-26-093465.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [42.3 d](/filings/0001558370-24-014753.md) | [15.8 d](/filings/0001104659-26-024735.md) | [1.6](/filings/0001558370-25-007430.md) | [41.5 d](/filings/0001558370-25-010646.md) | [14.6 d](/filings/0001104659-25-108820.md) | [21.1 d](/filings/0001104659-26-024735.md) | [(7.0)](/filings/0001104659-26-056683.md) | [21.7 d](/filings/0001104659-26-093465.md) | [61.6 d](/filings/0001104659-25-108820.md) | [1.0 d](/filings/0001104659-26-024735.md) | [28.2](/filings/0001104659-26-056683.md) | [(13.0) d](/filings/0001104659-26-093465.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [3.0](/filings/0001104659-26-056683.md) | [2.6 d](/filings/0001104659-26-093465.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [23.2](/filings/0001558370-23-018420.md) | [23.2](/filings/0001558370-24-007193.md) | [23.2](/filings/0001558370-24-011468.md) | [23.2](/filings/0001558370-24-014753.md) | [23.2](/filings/0001558370-25-007430.md) | [23.2](/filings/0001558370-25-010646.md) | [23.2](/filings/0001104659-25-108820.md) | [23.2](/filings/0001104659-26-056683.md) | [23.2](/filings/0001104659-26-093465.md) | [23.2](/filings/0001104659-25-108820.md) | [22.2](/filings/0001104659-26-056683.md) | [21.6](/filings/0001104659-26-093465.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 21,476,471 at 2026-08-10, from the cover of the [10-Q filed 2026-08-10](/filings/0001104659-26-093465.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.